The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
CB2receptors in the brain: role in central immune function
Open accessAbstract
Recently, it has been recognized that the cannabinoid receptor CB 2 may play a functionally relevant role in the central nervous system (CNS). This role is mediated primarily through microglia, a resident population of cells in the CNS that is morphologically, phenotypically, and functionally related to macrophages. These cells also express the cannabinoid receptor CB 1. The CB 1 receptor (CB1R) is constitutively expressed at low levels while the CB 2 receptor (CB2R) is expressed at higher levels and is modulated in relation to cell activation state. The relatively high levels of the CB2R correspond with microglia being in ‘responsive’ and ‘primed’ states, suggesting the existence of a ‘window’ of functional relevance during which activation of the CB2R modulates microglial activities. Signature activities of ‘responsive’ and ‘primed’ microglia are chemotaxis and antigen processing, respectively. The endocannabinoid 2‐arachidonylglycerol has been reported to stimulate a chemotactic response from these cells through the CB2R. In contrast, we have shown in vivo and in vitro that the exogenous cannabinoids delta‐9‐tetrahydrocannabinol and CP55940 inhibit the chemotactic response of microglia to Acanthamoeba culbertsoni, an opportunistic pathogen that is the causative agent of Granulomatous Amoebic Encephalitis, through activation of the CB2R. It is postulated that these exogenous cannabinoids superimpose an inhibitory effect on pro‐chemotactic endocannabinoids that are elicited in response to Acanthamoeba. Furthermore, the collective results suggest that the CB2R plays a critical immune functional role in the CNS. British Journal of Pharmacology(2008)153, 240–251; doi:10.1038/sj.bjp.0707584; published online 26 November 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“Transcripts (that is, mRNAs) for the CB1R and CB2R have been found in spleen and tonsils (Munro et al., 1993; Galiègue et al., 1995) and other immune tissues (Munro et al., 1993; Bouaboula et al., 1996).”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“Chemotaxis is the ability of cells to migrate in response to a stimulus and is distinctive from stimulus-independent random cellular motion (Lauffenburger and Horwitz, 1996; Mitchison and Cramer, 1996).”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,226
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Neuronal NADPH diaphorase is a nitric oxide synthase.
Hope, B. T., Michael, G. J., Knigge, K. M., & Vincent, S. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2811 · Cited by 1,908
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Koenig, S., Gendelman, H. E., Orenstein, J. M., Dal Canto, M. C., Pezeshkpour, G. H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3016903 · Cited by 1,698
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
The Cell Biology of Macrophage Activation
Adams, D. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.283 · Cited by 1,604
Actin-Based Cell Motility and Cell Locomotion
Mitchison, T. J., & Cramer, L. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81281-7 · Cited by 1,532
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
Snider, W. D., Simpson, D. M., Nielsen, S., Gold, W. M. J., Metroka, C. E., & Posner, J. B. (1983) · Annals of Neurology · doi:10.1002/ana.410140404 · Cited by 1,367
Acanthamoeba spp. as Agents of Disease in Humans
Marciano-Cabral, F., & Cabral, G. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.273-307.2003 · Cited by 1,290
Self-citationMicroglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
The Basis for the Immunoregulatory Role of Macrophages and Other Accessory Cells
Unanue, E. R., & Allen, P. M. (1987) · Science · doi:10.1126/science.2437650 · Cited by 1,021
Functional plasticity of microglia: A review
Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1988) · Glia · doi:10.1002/glia.440010502 · Cited by 940
Schwartz, R. (1985) · Annual Review of Immunology · doi:10.1146/annurev.immunol.3.1.237 · Cited by 932
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882
N-formylmethionyl peptides as chemoattractants for leucocytes.
Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 881
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Interleukin 1 of the central nervous system is produced by ameboid microglia.
Giulian, D., Baker, T. J., Shih, L. C., & Lachman, L. B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.2.594 · Cited by 859
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular Tropisms
Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., & Chen, I. S. Y. (1987) · Science · doi:10.1126/science.3646751 · Cited by 817
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDE
Hanahan, D. J. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.002411 · Cited by 774
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 694
The origin and nature of ramified and amoeboid microglia: A historical review and current concepts
Ling, E., & Wong, W. (1993) · Glia · doi:10.1002/glia.440070105 · Cited by 691
The role of microglia and macrophages in the pathophysiology of the CNS
Stollg, G., & Jander, S. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00083-5 · Cited by 683
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 533
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
Immunology: The ins and outs of antigen processing and presentations
Germain, R. N. (1986) · Nature · doi:10.1038/322687a0 · Cited by 496
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 482
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Howlett, A. C., Qualy, J. M., & Khachatrian, L. L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 469
Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461
Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 447
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419
C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor
Gerard, C., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 416
Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 393
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Fernández-Ruiz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362
Jaggar, S. I., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 354
HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease
Merrill, J. E., & Chen, I. S. Y. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.10.2065887 · Cited by 353
Carlisle, S. J., Marciano-Cabral, F., Staab, A., Ludwick, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344
Self-citationCarrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
[59] Inhibitors of lysosomal function
Seglen, P. O. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)96063-9 · Cited by 333
Molecular mechanisms of signal transduction in macrophages
Hamilton, T. A., & Adams, D. O. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90145-9 · Cited by 324
Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
Arévalo-Martı́n, Á., Vela, J. M., Molina-Holgado, E., Borrell, J., & Guaza, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314
Sim, L. J., Hampson, R. E., Deadwyler, S. A., & Childers, S. R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08057.1996 · Cited by 312
Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi‐Carmona, M., Calandra, B., Le Fur, G., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 286
Aloisi, F., Ria, F., Penna, G., & Adorini, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4671 · Cited by 276
Lynn, A. B., & Herkenham, M. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 276
Microglia in human disease, with an emphasis on acquired immune deficiency syndrome.
Dickson, D. W., Mattiace, L. A., Kure, K., Hutchins, K. D., Lyman, W. D., & Brosnan, C. F. (1991) · PubMed · Cited by 275
Immunological Self, Nonself Discrimination
Guillet, J.-G., Lai, M.-Z., Briner, T. J., Buus, S., Sette, A., Grey, H. M., Smith, J. A., & Gefter, M. L. (1987) · Science · doi:10.1126/science.2433769 · Cited by 274
Mannie, M. D. (1999) · Immunologic Research · doi:10.1007/bf02786477 · Cited by 265
Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
Goldman, D. W., & Goetzl, E. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1600 · Cited by 258
Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256
The search for the palmitoylethanolamide receptor
LoVerme, J., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.012 · Cited by 248
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<58::aid-glia6>3.0.co;2-w · Cited by 248
Self-citationSelective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 228
Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 222
Self-citationRole of Chemotaxis in Inflammation
Harris, H. (1954) · Physiological Reviews · doi:10.1152/physrev.1954.34.3.529 · Cited by 192
P2X7receptors control 2-arachidonoylglycerol production by microglial cells
Witting, A., Walter, L., Wacker, J., Möller, T., & Stella, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306707101 · Cited by 187
Kure, K., Lyman, W. D., Weidenheim, K. M., & Dickson, D. W. (1990) · PubMed Central · Cited by 186
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19238 · Cited by 185
Matsumoto, Y., Ohmori, K., & Fujiwara, M. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90152-b · Cited by 171
Microglia, the first line of defence in brain pathologies.
Kreutzberg, G. W. (1995) · PubMed · Cited by 164
Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 162
Cytokines: Influence on Glial Cell Gene Expression and Function
Benveniste, E. N. (1997) · KARGER eBooks · doi:10.1159/000058653 · Cited by 146
Ashton, J. C., Rahman, R. M. A., Nair, S. M., Sutherland, B. A., Glass, M., & Appleton, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.053 · Cited by 142
HUMAN IMMUNODEFICIENCY VIRUS AND THE CENTRAL NERVOUS SYSTEM
Spencer, D. C., & Price, R. W. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003255 · Cited by 141
Amoeboid and ramified microglia: Their interrelationship and response to brain injury
Leong, S. K., & Ling, E. (1992) · Glia · doi:10.1002/glia.440060106 · Cited by 140
Michaels, J., Price, R. W., & Rosenblum, M. (1988) · Acta Neuropathologica · doi:10.1007/bf00686974 · Cited by 138
Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A. E., Colombo, A., Parolaro, D., & Massi, P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.003 · Cited by 130
Eilbott, D. J., Peress, N. S., Burger, H., LaNeve, D., Orenstein, J. M., Gendelman, H. E., Seidman, R., & Weiser, B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3337 · Cited by 130
Sacerdote, P., Massi, P., Panerai, A. E., & Parolaro, D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00307-6 · Cited by 124
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition
Hájos, N., & Freund, T. F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00149-4 · Cited by 121
McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 116
Self-citationFranklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111
Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Kim, C. H. (2004) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008043339712 · Cited by 95
Begg, M., Mo, F.-M., Offertáler, L., Bátkai, S., Pacher, P., Razdan, R. K., Lovinger, D. M., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307258200 · Cited by 85
Reid, D. M., Perry, V. H., Andersson, P.-B., & Gordon, S. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90353-h · Cited by 76
Lipids as bioeffectors in the immune system
Cabral, G. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.013 · Cited by 75
Self-citationEndocannabinoids in Neuroimmunology and Stress
Carrier, E. J., Patel, S., & Hillard, C. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933023 · Cited by 72
Microglia: a sensor to threats in the nervous system?
Gehrmann, J. (1996) · Research in Virology · doi:10.1016/0923-2516(96)80220-2 · Cited by 71
Raborn, E. S., Marciano‐Cabral, F., Buckley, N. E., Martin, B. R., & Cabral, G. A. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9077-z · Cited by 70
Self-citationChemoattractant Receptor Signaling and the Control of Lymphocyte Migration
Kehrl, J. H. (2006) · Immunologic Research · doi:10.1385/ir:34:3:211 · Cited by 69
Distinct chemokinetic and chemotactic responses in neutrophil granulocytes
Keller, H. U., Wissler, J. H., Hess, M. W., & Cottier, H. (1978) · European Journal of Immunology · doi:10.1002/eji.1830080102 · Cited by 61
Thomas, B. F., Wei, X., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10481-3 · Cited by 61
Hamilton, T. A., Jansen, M., Somers, S. D., & Adams, D. O. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280103 · Cited by 58
Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55
Stefano, G. B., Salzet, M., Rialas, C. M., et al. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00030-8 · Cited by 51
Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae
Cabral, G. A., & Marciano‐Cabral, F. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.027 · Cited by 45
Self-citationMoving toward understanding eukaryotic chemotaxis
Jin, T., & Hereld, D. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.04.008 · Cited by 39
Stimulated neutrophil locomotion: chemokinesis and chemotaxis.
Becker, E. L. (1977) · PubMed · Cited by 36
Expression of Cannabinoid Receptor mRNA in Murine and Human Leukocytes
Daaka, Y., Klein, T., & Friedman, H. P. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1951-5_13 · Cited by 22
Marciano‐Cabral, F., Ferguson, T., Bradley, S. G., & Cabral, G. A. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00433.x · Cited by 21
Self-citationHarris, H. (1953) · PubMed · Cited by 19
Cited by
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2533 · Cited by 1,399
Crystal Structure of the Human Cannabinoid Receptor CB1
Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.004 · Cited by 673
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 414
Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408
Self-citation
Metadata
- Authors
- Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 153
- Issue
- 2
- Pages
- 240-251
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2028312992
- Cited by
- 342
- References
- 108
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.